2RR3

Solution structure of the complex between human VAP-A MSP domain and human OSBP FFAT motif

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCO	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
2	3D HN(CA)CO	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
3	3D HNCACB	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
4	3D HN(COCA)CB	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
5	3D C(CO)NH	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
6	3D H(CCO)NH	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
7	3D HCCH-TOCSY	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
8	4D HC(CO)NH	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
9	2D 1H-1H NOESY	1mM [U-15N] VAP-A MSP domain; 1mM [U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
10	3D 1H-15N TOCSY	1mM [U-15N] VAP-A MSP domain; 1mM [U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
11	3D HNCO	1mM VAP-A MSP domain; 1mM [U-13C; U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
12	3D HN(CA)CO	1mM VAP-A MSP domain; 1mM [U-13C; U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
13	3D HNCACB	1mM VAP-A MSP domain; 1mM [U-13C; U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
14	3D HN(COCA)CB	1mM VAP-A MSP domain; 1mM [U-13C; U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
15	3D C(CO)NH	1mM VAP-A MSP domain; 1mM [U-13C; U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
16	3D H(CCO)NH	1mM VAP-A MSP domain; 1mM [U-13C; U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
17	3D HCCH-TOCSY	1mM VAP-A MSP domain; 1mM [U-13C; U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
18	4D HC(CO)NH	1mM VAP-A MSP domain; 1mM [U-13C; U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
19	3D 1H-15N NOESY	1mM [U-15N] VAP-A MSP domain; 1mM [U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303
20	3D 1H-13C NOESY	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM [U-13C; U-15N] OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 100% D2O	100% D2O		6.9		303
21	3D 13C-edited/13C-filtered NOESY	1mM [U-13C; U-15N] VAP-A MSP domain; 1mM OSBP FFAT motif; 50mM potassium phosphate; 100mM potassium chloride; 1mM DTT; 0.1mM EDTA; 93% H2O/7% D2O	93% H2O/7% D2O		6.9		303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Bruker	DRX	800

NMR Refinement
Method	Details	Software
molecular dynamics		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	300
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	data analysis	Sparky		Goddard
3	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
4	refinement	Amber	9	Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, and Kollm